Loading...
XSTO
GETI B
Market cap5.52bUSD
Apr 16, Last price  
195.90SEK
1D
-0.73%
1Q
2.67%
Jan 2017
36.04%
Name

Getinge

Chart & Performance

D1W1MN
No data to show
P/E
32.82
P/S
1.55
EPS
5.97
Div Yield, %
2.25%
Shrs. gr., 5y
—
Rev. gr., 5y
5.53%
Revenues
34.76b
+9.21%
11,880,400,00013,001,000,00016,445,000,00019,272,000,00022,816,000,00022,172,000,00021,854,000,00024,248,000,00025,287,000,00026,669,000,00030,235,000,00029,756,000,00022,495,000,00024,172,000,00026,559,000,00029,819,000,00027,049,000,00028,291,000,00031,827,000,00034,759,000,000
Net income
1.64b
-32.09%
1,138,400,0001,254,000,0001,260,000,0001,523,000,0001,914,000,0002,277,000,0002,529,000,0002,521,000,0002,285,000,0001,433,000,0001,390,000,0001,188,000,0001,376,000,000-967,000,0001,222,000,0003,239,000,0002,970,000,0002,491,000,0002,412,000,0001,638,000,000
CFO
4.58b
+54.79%
1,169,300,0001,504,500,0001,328,000,0001,475,000,0004,000,000,0004,124,000,0003,496,000,0003,687,000,0003,544,000,0003,473,000,0003,458,000,0003,671,000,0002,763,000,0002,503,000,0003,832,000,0007,199,000,0006,560,000,0003,367,000,0002,957,000,0004,577,000,000
Dividend
Apr 23, 20250 SEK/sh
Earnings
Apr 21, 2025

Profile

Getinge AB (publ) provides products and solutions for operating rooms, intensive-care units, and sterilization departments. The company operates through Acute Care Therapies, Life Science, and Surgical Workflows segments. It offers sterile transfer systems, closure processing systems, washers, isolators, sterilizers, logistic automation solutions, bioreactors, bioprocess control systems, bioprocess software, biobundles, bioprocess analytics, and perfusion systems; practice-oriented monitoring systems and disposables, anesthesia machines, beating heart stabilizers and positioners, axius blower mister and coronary shunts, proximal seal systems, ceiling supply units, connected solutions, cleaning and disinfection products, packaging and sealing solutions, monitors and indicators, and SteriTec products. The company also provides thoracic catheters, dry seal chest drain, mobile dry seal drain, dry and wet suction water seal chest drain, and chest drain valves; transitional accessories; endoscope reprocessing; endoscopic vessel harvesting systems; endovascular products; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packing products; intra-aortic balloon counter pulsation therapies; mechanical ventilation products; medical furniture; modular room systems; operating lights and tables; OR integration and management; patient flow management; patient transport; sterile supply management; sterilization; surgical assist systems; surgical perfusion; transport & storage; trays & baskets; and vascular and cardiothoracic surgery solutions. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Getinge AB (publ) was founded in 1904 and is headquartered in Gothenburg, Sweden.
URL
https://www.getinge.com/
IPO date
Jun 08, 1995
Employees
11,098
Domiciled in
SE
Incorporated in
SE

Valuation

Title
SEK in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
34,759,000
9.21%
31,827,000
12.50%
28,291,000
4.59%
Cost of revenue
30,670,000
27,998,000
24,453,000
Unusual Expense (Income)
NOPBT
4,089,000
3,829,000
3,838,000
NOPBT Margin
11.76%
12.03%
13.57%
Operating Taxes
628,000
915,000
956,000
Tax Rate
15.36%
23.90%
24.91%
NOPAT
3,461,000
2,914,000
2,882,000
Net income
1,638,000
-32.09%
2,412,000
-3.17%
2,491,000
-16.13%
Dividends
(1,227,000)
(1,158,000)
(1,090,000)
Dividend yield
2.48%
1.90%
1.85%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
2,447,000
3,116,000
793,000
Long-term debt
10,080,000
6,439,000
6,345,000
Deferred revenue
1,513,000
Other long-term liabilities
5,209,000
4,870,000
3,405,000
Net debt
9,566,000
6,766,000
1,412,000
Cash flow
Cash from operating activities
4,577,000
2,957,000
3,367,000
CAPEX
(1,309,000)
(1,353,000)
(1,136,000)
Cash from investing activities
(4,549,000)
(6,543,000)
(1,470,000)
Cash from financing activities
504,000
511,000
(500,000)
FCF
4,607,000
567,000
1,100,000
Balance
Cash
2,961,000
2,728,000
5,676,000
Long term investments
61,000
50,000
Excess cash
1,223,050
1,197,650
4,311,450
Stockholders' equity
20,669,000
23,614,000
23,664,000
Invested Capital
47,922,950
40,638,350
34,928,550
ROIC
7.82%
7.71%
8.80%
ROCE
7.97%
8.80%
9.50%
EV
Common stock shares outstanding
272,370
272,370
272,370
Price
181.55
-19.06%
224.30
3.70%
216.30
-45.25%
Market cap
49,448,774
-19.06%
61,092,495
3.70%
58,913,539
-45.25%
EV
59,219,774
68,095,495
60,740,539
EBITDA
6,510,000
5,922,000
5,865,000
EV/EBITDA
9.10
11.50
10.36
Interest
493,000
205,000
Interest/NOPBT
12.88%
5.34%